{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3157.4020","meta":{"versionId":"14","lastUpdated":"2022-03-08T01:01:59.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4020","version":"20200821","name":"Fibrinolytic Therapy","status":"active","date":"2022-03-08T01:02:00-05:00","publisher":"Yale","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4019"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4018"]}]},"expansion":{"identifier":"urn:uuid:be5573bc-e0a5-4e38-8e73-5b8ae495fb9d","timestamp":"2022-06-10T07:41:45-04:00","total":69,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1008478","display":"dornase alfa / streptokinase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"10105","display":"streptodornase / streptokinase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"10106","display":"streptokinase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"11055","display":"urokinase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1155608","display":"alteplase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1159983","display":"urokinase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1161753","display":"streptokinase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1164230","display":"tenecteplase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1164834","display":"reteplase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1169913","display":"Activase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1171399","display":"Kinlytic Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1177312","display":"Tnkase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1182533","display":"Retavase Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804797","display":"alteplase 100 MG"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804798","display":"alteplase Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804799","display":"alteplase 100 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804800","display":"alteplase 100 MG [Activase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804801","display":"alteplase Injection [Activase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804802","display":"alteplase 100 MG Injection [Activase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804803","display":"alteplase 50 MG"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804804","display":"alteplase 50 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804805","display":"alteplase 50 MG [Activase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1804806","display":"alteplase 50 MG Injection [Activase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1809070","display":"tenecteplase 50 MG"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1809071","display":"tenecteplase Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1809073","display":"tenecteplase 50 MG [Tnkase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1809074","display":"tenecteplase Injection [Tnkase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1867708","display":"reteplase 10 UNT"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1867709","display":"reteplase Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1867711","display":"reteplase 10 UNT [Retavase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1867712","display":"reteplase Injection [Retavase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"204210","display":"Activase"},{"system":"http://loinc.org","version":"2.72","code":"21464-3","display":"Plasminogen activator urokinase type [Presence] in Tissue"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"219642","display":"Retavase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"259280","display":"tenecteplase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"284422","display":"tenecteplase 50 MG Injection [Tnkase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"284879","display":"Tnkase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"313212","display":"tenecteplase 50 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"343105","display":"urokinase 5000 UNT/ML"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"351023","display":"urokinase 50000 UNT/ML"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"378685","display":"urokinase Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"40028","display":"anistreplase"},{"system":"http://loinc.org","version":"2.72","code":"43636-0","display":"Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"465347","display":"urokinase 5000 UNT/ML Injectable Solution"},{"system":"http://loinc.org","version":"2.72","code":"5971-7","display":"Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.72","code":"5972-5","display":"Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis"},{"system":"http://loinc.org","version":"2.72","code":"5973-3","display":"Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis"},{"system":"http://loinc.org","version":"2.72","code":"5981-6","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.72","code":"5982-4","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis"},{"system":"http://loinc.org","version":"2.72","code":"5983-2","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis"},{"system":"http://loinc.org","version":"2.72","code":"5986-5","display":"Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.72","code":"5987-3","display":"Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.72","code":"5988-1","display":"Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis"},{"system":"http://loinc.org","version":"2.72","code":"5989-9","display":"Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis"},{"system":"http://loinc.org","version":"2.72","code":"5990-7","display":"Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"608930","display":"urokinase 50000 UNT/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"763138","display":"reteplase 10 UNT Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"763141","display":"reteplase 10 UNT Injection [Retavase]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"763567","display":"Kinlytic"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"763568","display":"urokinase 50000 UNT/ML [Kinlytic]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"763569","display":"urokinase Injectable Solution [Kinlytic]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"763570","display":"urokinase 50000 UNT/ML Injectable Solution [Kinlytic]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"76895","display":"reteplase"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"8410","display":"alteplase"},{"system":"http://loinc.org","version":"2.72","code":"88659-8","display":"Timing of thrombolytic administration in relation to cardiac arrest"},{"system":"http://loinc.org","version":"2.72","code":"LP16885-3","display":"Plasminogen activator tissue type Ag"},{"system":"http://loinc.org","version":"2.72","code":"LP16889-5","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex"},{"system":"http://loinc.org","version":"2.72","code":"LP16891-1","display":"Plasminogen activator tissue type"},{"system":"http://loinc.org","version":"2.72","code":"LP265990-4","display":"Timing of thrombolytic administration in relation to cardiac arrest"}]}}